Drugs / Tetanus toxoid vaccine
last change Dec 2022 re-read 9 days ago

Tetanus toxoid vaccine

Vaccine

Developed for
tetanus
Investigated by
Epicentre · National Institute of Allergy and Infectious Diseases (NIAID) · Providence Health & Services · University of Nebraska

Trials 4

19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT01644968 Nov 2003 → May 2009 cancer of unknown primary site Providence Health & Services Completed No outcome recorded
Phase 21 trial
Phase 2 NCT02700841 Jan 2020 → Dec 2022 plasma cell myeloma University of Nebraska Terminated No outcome recorded Stop: Enrollment
Phase not applicable2 trials
— NCT01559597 Nov 2012 → Mar 2013 tetanus Epicentre Completed No outcome recorded
— NCT00001119 Oct 1999 → Jun 2004 HIV infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded
Comparator or background therapy5 trials
Phase 1 NCT02109354 Comparator Jun 2013 → Feb 2015 HIV infectious disease HIV Vaccine Trials Network Completed No outcome recorded
Phase 1 NCT00279734 Background Aug 2004 → Jan 2005 rheumatoid arthritis Bristol-Myers Squibb Completed No outcome recorded
Phase 2 NCT00008866 Background — HIV infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Withdrawn No outcome recorded
Phase 3 NCT01199861 Background Aug 2010 → May 2011 multiple sclerosis Novartis Completed No outcome recorded
— NCT00000943 Background ? → Nov 2005 HIV infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 9 sources stand behind the page.

FieldValueCited text
Known as Tetanus Toxoid Vaccine “Tetanus toxoid vaccine 0.5ml (5 LF/ml tetanus toxoid)on Day 29” NCT01644968 ↗
8

“the intramuscular tetanus toxoid vaccine” PMID 17425783 ↗ 2007

NCT02700841 ↗

NCT01559597 ↗

NCT00001119 ↗

NCT02109354 ↗

NCT00008866 ↗

NCT00000943 ↗

NCT01199861 ↗

Modality Vaccine “Tetanus Toxoid Vaccine” NCT00000943 ↗
Route Intramuscular “intramuscular vaccination with tetanus toxoid” NCT00001119 ↗